CRISPR 101

New CRISPR article every month🧬

#CRISPR #GeneEditing (DP and banner created on Biorender)

[Synthego @Synthego]

[ECLIPSE IS HERE!] Eclipse™ is a groundbreaking #CRISPR-editing platform that delivers the new gold standard in cell-based models. Leave no variant, gene, or mutation unstudied, ever again. Get started: https://t.co/Bc9VcNTJ6F

[Andrea Ventura @aventura71]

We have two postdoctoral positions open to work on mouse models of cancer, ecDNAs, somatic chromosomal engineering, CRISPR-screens, and non-coding RNAs.
MSKCC is a great place to do research. If you are interested email me: [email protected]

Please retweet!

[CRISPR MEMES @CrisprMemes]

The U.S. Patent and Trademark Office ruled in favor of the opportunistic pathogen, following research showing the use of CRISPR for editing its own genome.

S. epidermidis is thought to have invented the technique several hundred million years before both the Broad Institute...

[Can Dincer @CanDincer83]

Glad to see our paper (Nr. 11) "#CRISPR #biosensor X for multiplexed and amplification-free miRNA #diagnostics" within the most downloaded articles from Biosensors & Bioelectronics in the last 90 days🤩 Thanks a lot for your interest🙏

https://t.co/YEOSr7HB6Z

[Randall Platt @randall_platt]

We are recruiting at multiple levels! Interested in developing CRISPR and AAV technologies while working with a great team in Switzerland? We are seeking applications for a Lab Manager, Postdoc, and Research Technician. More info at: https://t.co/eZfGvtVBFA

[CRISPR Therapeutics @CRISPRTX]

We’re pleased to present new preclinical data on our CAR-T program at the #AACR21 annual meeting. Learn more here: https://t.co/2qiNhbvRM3

[CRISPR Therapeutics @CRISPRTX]

Thank you @BlackRock for having $CRSP CEO @CrisprSam on The Bid podcast to discuss how we have advanced clinical trials for CRISPR-based medicines to treat serious diseases including #SickleCell, #BetaThalassemia and cancer.

[CRISPR Therapeutics @CRISPRTX]

At CRISPR, we believe in equal access to quality health care. National Minority Health Month highlights the strides taken to decrease medical disparities affecting underrepresented communities while acknowledging there is more work to be done.

[ERS Genomics @ersgenomics]

CRISPR has been used to identify factors essential for #SARSCoV2 infection in humans.

A genome-wide #CRISPR screen uncovered potential targets which may be exploited to develop drugs again SARS-CoV-2 infection.

Read more @NatureGenet: https://t.co/TAFp5DubHl

[Feng Zhang @zhangf]

We are pleased to share a follow-up story to our study of CRISPR-associated transposases (CAST) led by Makoto Saito, @LadhaAlim, @thestrecker, and Guilhem Faure: https://t.co/R8lCNnKUYR. 1/5

[CRISPR MEMES @CrisprMemes]

check yourself before you wreck your cells #crispr #memes

[ERS Genomics @ersgenomics]

#CRISPR has been used to create brain-like 'organoids' using human #stemcells.

The organoids, containing an ancient version of NOVA1, the gene influencing brain development, were smaller and bumpier than those with human #genes.

Read more @nresearchnews: https://t.co/WdeXCziqhh

[SynBioBeta @SynBioBeta]

SynBioBeta is hosting a special event to answer all your burning biopharma questions. What’s the current state of #CRISPR-based medicine? What new investors are entering the #biopharma space? What’s next for mRNA vaccines? https://t.co/wB7yZCqMyL

[Genetic Engineering & Biotechnology News @GENbio]

30 MINUTES FROM NOW, join us Live for The Story of CRISPR: Walter Isaacson.

We’ll talk to @WalterIsaacson about his new book, #CRISPR, #COVID19, and more! Please also leave a question down below that you would like to #askWalter. Register now: https://t.co/7PImKA11Kg

[Genetic Engineering & Biotechnology News @GENbio]

#CRISPR 2.0: Base Editing in the Groove
A series of exciting preclinical and animal model results show that #baseediting is making rapid strides toward the clinic. Learn more: https://t.co/BrCMuDaUxu

[Can Dincer @CanDincer83]

Glad to welcome you to TheScientist-Webinar #CRISPR #Biosensors for #Disease #Diagnostics", on next Friday at 8:30 (CET) where I will present our CRISPR-Biosensor along with initial results on multiplexed & amplification-free COVID-19 testing🙂

https://t.co/3KTd0kBbGV

[CRISPR News 🧬 @CRISPR_News]

CRISPR-based treatment successfully tested in mice to stop the replication of both the flu virus and the virus that causes COVID-19. Treatment is delivered to the lungs via a nebulizer. https://t.co/I3ldrKQsfy @GeorgiaTech @EmoryUniversity

[CRISPRpapers @CRISPR_papers]

CRISPR-SE: a brute force search engine for CRISPR design https://t.co/syBb0ya6h4

[Daniël Warmerdam @WarmerdamDaniel]

Cas9 deactivation with photocleavable guide RNAs https://t.co/96XwC0gv65

[ERS Genomics @ersgenomics]

ERS Genomics today announced a non-exclusive license agreement granting Otsuka Pharmaceutical access to ERS Genomics’ CRISPR/Cas9 #patent portfolio.

Otsuka Pharmaceutical is using #CRISPR technology for research and development.

Read more: https://t.co/bWJYIFFIw6